Hamlet BioPharma AB

ABActive

Org 5565688958Klinikgatan 32, 222 42 LundResearch and experimental development on natural sciences and engineering· NACE 7210Est. 1999 · 27 years old5-9 employees

Overview Financials People & ownership Related companies

Hamlet BioPharma AB is a Swedish AB based in Lund, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 1999, the company reported revenue of SEK 0 in its latest annual filing.

Revenue 2025

SEK 0

EBITDA margin

—

Net profit 2025

SEK 54M

+236% vs 2024

Key ratios

See full ratios →

84.9%

This company

20212025

1.8×

This company

20212025

112.3%

This company

20212025

EBITDA — year on year

SEK millions

Key figures

Annual report 2025

Revenue	SEK 0	—
EBITDA	SEK 62M	+288%
Net profit	SEK 54M	+236%
Total assets	SEK 48,1M	-32%
Equity	SEK 40,8M	-39%
Employees	—	—

Contact

Address

Klinikgatan 32, 222 42 Lund

Phone

+4646328477

martin.erixon@hamletpharma.com

Risika for professionals

Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.

Visit risika.com

Frequently asked questions

What is the Org number of Hamlet BioPharma AB?

Hamlet BioPharma AB is registered with Bolagsverket / SCB under Org 5565688958.

Who is the CEO of Hamlet BioPharma AB?

Per Anders Jakob Testad is the CEO of Hamlet BioPharma AB, in role since 2025.

Who is the chairman of Hamlet BioPharma AB?

Marianne Catharina Svanborg chairs the board of Hamlet BioPharma AB, in role since 2025.

Where is Hamlet BioPharma AB headquartered?

Hamlet BioPharma AB's registered address is Klinikgatan 32.

Hamlet BioPharma AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Hamlet BioPharma AB

Key ratios

EBITDA — year on year

Key figures

Company information

Contact

Frequently asked questions

More on Hamlet BioPharma AB